Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_assertion type Assertion NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_head.
- NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_assertion description "[Urokinase-type plasminogen activator (uPA) is thought to be critically involved in the metastatic phenotype of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_provenance.
- NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_assertion evidence source_evidence_literature NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_provenance.
- NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_assertion SIO_000772 18225541 NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_provenance.
- NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_assertion wasDerivedFrom befree-2016 NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_provenance.
- NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_assertion wasGeneratedBy ECO_0000203 NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_provenance.